Rachael Brake

Rachael Brake

Chief Scientific OfficeratCorbus Pharmaceuticals Holdings· In proxies 2022–2023

Pay in FY2023+10% from the year before · Corbus Pharmaceuticals Holdings stock +82.2% the same year

Rachael Brake was paid $839.9K in FY2023 (Dec), up 10%. Corbus Pharmaceuticals Holdings stock rose 82.2% that year.

Pay$100 in the stock at the end of FY21 → $33
Pay is from the Summary Compensation Table of each Corbus Pharmaceuticals Holdings proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Corbus Pharmaceuticals HoldingsPublic company · 4 yr
    • Chief Scientific Officer2022 – Present · 4 yrStock in role -78%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?